combination
Showing 9976 - 10000 of >10,000
Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Lenalidomide, Prednisone)
Completed
- Myeloproliferative Diseases
- Ruxolitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 8, 2019
Acute Myeloid Leukemia Trial in Hershey (Avelumab)
Terminated
- Acute Myeloid Leukemia
-
Hershey, PennsylvaniaPenn State Cancer Institute
Aug 19, 2019
Metabolic Syndrome, Hypertriglyceridemia Trial in Sioux Falls (omega-3 acid ethyl esters, extended release niacin, )
Completed
- Metabolic Syndrome
- Hypertriglyceridemia
- omega-3 acid ethyl esters
- +3 more
-
Sioux Falls, South DakotaSanford Clinic Clinical Research Services
Sep 28, 2021
Comparative Effectiveness of COPD Treatments
Completed
- Pulmonary Disease, Chronic Obstructive
- LABA and the LAMA tiotropium (LABA-TIO)
- LABA and an ICS (LABA-ICS)
-
Montreal, CanadaCentre for Clinical Epidemiology, McGill University
Jul 10, 2019
Melanoma Trial in Omaha (Pembrolizumab, Interleukin-2)
Terminated
- Melanoma
-
Omaha, NebraskaNebraska Cancer Specialists
Oct 18, 2019
Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- Intensity-modulated radiotherapy concurrent with capecitabine
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer center
Aug 21, 2022
Epidermoid Carcinoma, Anus Trial in France (radiochemo, Panitumumab)
Completed
- Epidermoid Carcinoma
- Anus
-
Bordeaux, France
- +14 more
Mar 23, 2022
Pulmonary Cancer Trial (Laser Speckle Contrast Imaging using the PerfusiX-Imaging Device)
Recruiting
- Pulmonary Cancer
- Laser Speckle Contrast Imaging using the PerfusiX-Imaging Device
-
Leeuwarden, Friesland, NetherlandsMedical Center Leeuwarden
Jan 5, 2023
Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia, Acinetobacter Pneumonia Trial (Cefiderocol,
Not yet recruiting
- Carbapenem Resistant Bacterial Infection
- +2 more
- Cefiderocol
- +3 more
- (no location specified)
Jun 18, 2023
Tumors, Breast Trial in Worldwide (lapatinib, trastuzumab, Aromatase inhibitor)
Active, not recruiting
- Neoplasms, Breast
- lapatinib
- +2 more
-
La Jolla, California
- +229 more
Aug 27, 2021
Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)
Recruiting
- Cardiac Surgery
- Nirmatrelvir/ritonavir
- Ursodeoxycholic acid
-
Beijing, Beijing, ChinaFuwai Hospital
Jan 18, 2023
Cerebrovascular Accident Trial in Cleveland (upper limb rehabilitation for chronic stroke)
Completed
- Cerebrovascular Accident
- upper limb rehabilitation for chronic stroke
-
Cleveland, OhioLouis Stokes Cleveland Department of Veterans Affairs Medical Ce
Apr 4, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Terminated
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- bortezomib
- +2 more
-
Houston, TexasMD Anderson Cancer Network
Oct 30, 2019
Myocarditis, Cardiac Sarcoidosis, Pericarditis Trial in Bern
Enrolling by invitation
- Myocarditis
- +2 more
-
Bern, SwitzerlandDepartment of Cardiology, University Hospital Bern, Inselspital,
May 17, 2022
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023
Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology
Not yet recruiting
- Pseudomyxoma Peritonei
- +3 more
- Bromelain
- +2 more
- (no location specified)
Feb 28, 2022
The PROMISE Pediatric Study 6 to 11 Years Old
Active, not recruiting
- Cystic Fibrosis
- Cystic Fibrosis in Children
-
Birmingham, Alabama
- +19 more
Sep 7, 2022
Metabolic Health Trial in Bothell (VIOME Precision Nutrition Program, VIOME-designed condition-based supplements)
Not yet recruiting
- Metabolic Health
- VIOME Precision Nutrition Program
- VIOME-designed condition-based supplements
-
Bothell, WashingtonViome Life Sciences
Dec 23, 2022
Non-Alcoholic Fatty Liver Disease Trial in Kurdistan (Multiviamins and minerals, Placebo)
Completed
- Non-Alcoholic Fatty Liver Disease
- Multiviamins and minerals
- Placebo
-
Kurdistan, Kalar, IraqHawal Fateh
Jun 8, 2023
Generalized Anxiety Disorder Trial in Toronto (Dietary Counselling combined with Omega-3 Supplementation)
Recruiting
- Generalized Anxiety Disorder
- Dietary Counselling combined with Omega-3 Supplementation
-
Toronto, Ontario, CanadaCanadian College of Naturopathic Medicine
Jan 10, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Postoperative Recurrence by Intestinal Ultrasound After
Recruiting
- Crohn Disease
- Intestinal ultrasound
-
Lüneburg, Germany
- +4 more
Jan 27, 2023